Total Funding
20
26
Total FundingSeries C raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
95089
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
James R. Schmidt: Vice President, Finance and AdministrationPast Role: Receptos, Vice President Finance & Administration
Joshua Grass: Chief Executive OfficerPast Role: Modis Therapeutics, CEO
About the Company
Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the advancement of first-in-class G Protein-Coupled Receptor targeted drugs. Its services focus on offering therapies for neuro-immuno-inflammatory and autoreactive diseases.
